• Newspaper/Magazine Article
  • Published June 2008

FDA Advise-ERR: prevent dangerous drug-device interaction causing falsely elevated glucose levels.

This article addresses a drug–device interaction in which patients receiving a certain peritoneal dialysis solution may have falsely elevated blood glucose levels when measured with point-of-care blood glucose monitors.

Back to Top